This page is a guide to BBP, the BioShares Biotechnology Products offered by BioShares.
Last Price
$21.75
-1.49%
How is BBP Categorized as an ETF?
All ETFs
1,754 funds
Asset Class
985 ETFs
Category
273 ETFs
Sub-Category
9 ETFs
How Does BBP Compare to Its Category Competitors?
The percentile shown for each metric indicates how BBP compares to other ETFs in the Sector Stock category. Wondering how percentiles work? Short version: 99th percentile is good, 0th is bad.
Assets and Yield
Assets (Millions)
$16.87
15th Percentile
Dividend Yield
1.65%
45th Percentile
Returns
YTD Return
-21.70%
2nd Percentile
5 Year Return
N/A
N/A
Portfolio
Number of Holdings
35
31st Percentile
% Assets in Top 10
32.81%
73rd Percentile
Expenses
Expense Ratio
0.85%
6th Percentile
Fund Turnover
N/A
N/A
BBP vs. Other Sector Stock ETFs: All the Data You Could Possibly Want
The table below shows additional financial metrics for BBP as well as all other ETFs in the Sector Stock category. To compare BBP to its broader asset class peer group, visit the Stock page. To compare BBP to its narrower sub-category peer group, visit the Biotech ETFs page.
Click on the tabs (Expenses, Returns, Yield, Holdings) to view additional data for BBP and all ETFs in the Sector Stock category.
| Ticker | ETF | Assets ($M) | Inception Date | Issuer |
|---|---|---|---|---|
| Category Average | N/A | $821.16 | N/A | N/A |
| Ticker | ETF | Expense Ratio | Fund Turnover |
|---|---|---|---|
| Category Average | N/A | 0.62% | 33.14% |
| Ticker | ETF | YTD | 1-Month | 3-Month | 6-Month | 1-Year | 3-Year | 5-Year | 10-Year |
|---|---|---|---|---|---|---|---|---|---|
| Category Average | N/A | -7.91% | -7.58% | -11.49% | -15.36% | -13.96% | 1.53% | 2.85% | 5.10% |
| Ticker | ETF | 12 Month Yield | 30 Day SEC Yield | Dividend Frequency | Capital Gains Frequency |
|---|---|---|---|---|---|
| Category Average | N/A | 3.03% | 2.29% | N/A | N/A |
| Ticker | ETF | Number of Holdings | Number of Long Holdings | Number of Short Holdings | % Assets in Top 10 |
|---|---|---|---|---|---|
| Category Average | N/A | 84 | 84 | 2 | 47.79% |
BBP Portfolio
| Asset Class | Weight |
|---|---|
| US Stock Weighting | 100.00% |
| Top Holdings | Weight |
|---|---|
| Theravance Biopharma Inc | 3.67% |
| Vanda Pharmaceuticals Inc | 3.39% |
| Acorda Therapeutics Inc | 3.37% |
| Biogen Inc | 3.31% |
| Amgen Inc | 3.30% |
| Ligand Pharmaceuticals Inc | 3.29% |
| Exelixis Inc | 3.14% |
| The Medicines Co | 3.14% |
| Nektar Therapeutics Inc | 3.10% |
| Raptor Pharmaceutical Corp | 3.09% |
Other BBP Metrics
Management
- Issuer
- BioShares
- Inception Date
- 12/16/2014
- Management Style
- Passive
- Benchmark
- BioShares Biotech Products TR USD
Dividend Data
- Dividend Frequency
- Quarterly
- Capital Gains Frequency
- N/A
- Annual Dividend
- N/A
Pricing Data
- Day Range
- $21.67 / $22.06
- Bid/Ask
- $21.86 / $21.95
- 52 Week Low/High
- $21.47 / $38.63
Other Information
- Leveraged Fund
- No
